ODYS Odysight.ai Inc.
Price Chart
Executive Summary
Odysight.ai filed a 424B5 prospectus supplement for an 'at-the-market' equity offering of up to $20M in common stock via Roth Capital Partners. The filing authorizes significant dilution — up to 27% of current shares at the June 4 close of $4.33 — for working capital and R&D. The stock trades at $4.33, down from $7.30 used for the public float calculation in April, and the company operates from Israel amid ongoing regional conflict.
Actionable Insight
This ATM facility creates persistent overhang — Roth can sell shares into the market daily at the company's discretion. The stock has already declined 41% from the $7.30 reference price used in the S-3. Watch daily volume and any Form 4 filings indicating CEO or insider sales, which would signal urgency. The cross-filing with S-3, restructuring context (recent 8-Ks), and press context all amplify the impact per the actuarial verdicts. Near-term price action is likely negative as the market absorbs the dilution potential.
Key Facts
- At-the-market offering of up to $20,000,000 in common stock via Roth Capital Partners (3% commission).
- Maximum of ~4,618,937 shares at $4.33 (June 2 close), representing ~27% dilution from 16.8M shares outstanding.
- Net tangible book value per share would rise from $1.26 to $1.88, but new investors would experience $2.45 per share dilution.
- Public float at April 9 was ~$63.5M (8.7M non-affiliate shares at $7.30); stock has since dropped to $4.33.
- Proceeds for R&D, sales & marketing, working capital — management has broad discretion.
- Company operates in Israel with disclosed geopolitical risks from ongoing Iran/Hezbollah conflicts.
- Shelf registration (S-3) filed Jan 30, 2026 for up to $200M; this $20M takedown is the first under it.
- No minimum offering amount — there is no guarantee any shares will be sold.
Financial Impact
Potential dilution of up to 27% of outstanding shares (4.6M new shares) raising up to $20M gross proceeds. Net proceeds after 3% commission and ~$225K expenses would be ~$19.2M. The ATM structure allows continuous selling pressure over time.
Risk Factors
- Continuous dilution risk — no limit on daily sales volume under the ATM program.
- Stock price decline from $7.30 to $4.33 (-41%) in ~2 months suggests deteriorating fundamentals or market sentiment.
- Israeli operations face direct geopolitical risk from ongoing military conflicts (Iran, Hezbollah) which could disrupt operations.
- Management has broad discretion on use of proceeds with no specific ROI commitments.
- History of operating losses cited in forward-looking statements — cash needs may require further offerings.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-027520 |
| Document: 0001493152-26-027520-index-headers.html | 0001493152-26-027520 |
| Document: 0001493152-26-027520-index.html | 0001493152-26-027520 |
| Document: 0001493152-26-027520.txt | 0001493152-26-027520 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
1d ago
|
424B5
| $3.85 awaiting T+20 | awaiting T+20 | — | $3.99 (−3.64%) |
|
Jun 5, 2026
1d ago
|
8-K
| — | awaiting T+20 | — | — |
|
May 21, 2026
16d ago
|
8-K
| — | awaiting T+20 | — | — |
|
May 14, 2026
23d ago
|
8-K
| — | awaiting T+20 | — | — |
|
Apr 17, 2026
7w ago
|
Press Release
| $5.40 $4.52 | ▼ −16.30% | ▼ −21.67% | $3.99 (−26.11%) |
|
Apr 10, 2026
8w ago
|
8-K
| $6.32 $4.56 | ▼ −27.85% | ▼ −36.38% | $3.99 (−36.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access